jueves, 2 de julio de 2020

Pharma firms need extra corruption vigilance during a pandemic - STAT

Pharma firms need extra corruption vigilance during a pandemic - STAT

The Readout

Damian Garde & Meghana Keshavan

More reads

  • Inside Moderna: the Covid vaccine front-runner with no track record and an unsparing CEO. (Wall Street Journal)
  • Novartis pays $678 million to settle a long-running case over alleged kickbacks to doctors (STAT Plus)
  • Nasdaq's $1.2 trillion biotech index draws Europe's COVID drug hunters. (Reuters)
  • Pharma companies need extra anti-corruption vigilance during a pandemic. (STAT)

No hay comentarios: